DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 165 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,946,089 | -14.0% | 240,762 | -3.0% | 0.01% | -15.4% |
| Q3 2022 | $4,591,000 | -62.8% | 248,166 | -73.5% | 0.01% | -61.8% |
| Q2 2022 | $12,326,000 | -32.1% | 937,317 | -52.2% | 0.03% | -17.1% |
| Q1 2022 | $18,161,000 | +114.0% | 1,959,078 | +125.5% | 0.04% | +156.2% |
| Q4 2021 | $8,487,000 | +1970.0% | 868,710 | +12004.1% | 0.02% | +1500.0% |
| Q4 2020 | $410,000 | +20400.0% | 7,177 | +17842.5% | 0.00% | – |
| Q3 2020 | $2,000 | -98.6% | 40 | -98.3% | 0.00% | – |
| Q2 2020 | $141,000 | -98.3% | 2,355 | -98.8% | 0.00% | -100.0% |
| Q1 2020 | $8,172,000 | -44.9% | 198,503 | -16.7% | 0.02% | -27.3% |
| Q4 2019 | $14,830,000 | +5196.4% | 238,277 | +2790.3% | 0.03% | +3200.0% |
| Q3 2019 | $280,000 | -74.8% | 8,244 | -71.3% | 0.00% | -66.7% |
| Q3 2018 | $1,113,000 | – | 28,756 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
| SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
| Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
| Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
| Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
| Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
| Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
| Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |